{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:51:47Z","timestamp":1786985507522,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["brainstimjrnl.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Stimulation"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.brs.2025.08.015","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T03:01:09Z","timestamp":1755745269000},"page":"1600-1607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between concomitant anticonvulsants and clinical and cognitive outcomes of electroconvulsive therapy for depression"],"prefix":"10.1016","volume":"18","author":[{"given":"Kevin","family":"McDonnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7653-8531","authenticated-orcid":false,"given":"Ana","family":"Jelovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2425-5062","authenticated-orcid":false,"given":"Christopher","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2545-3662","authenticated-orcid":false,"given":"Emma","family":"Whooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Igoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5684-7913","authenticated-orcid":false,"given":"Cathal","family":"McCaffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0146-6601","authenticated-orcid":false,"given":"Sarah","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4574-2799","authenticated-orcid":false,"given":"Declan M.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9360","key":"10.1016\/j.brs.2025.08.015_bib1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.brs.2025.08.015_bib2","article-title":"Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis","volume":"364","author":"Mutz","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.brs.2025.08.015_bib3","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24br15655","article-title":"Ketamine vs electroconvulsive therapy in the management of treatment-resistant depression: do we need more data?","volume":"86","author":"Rhee","year":"2025","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1192\/bjp.2017.28","article-title":"Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis","volume":"212","author":"van Diermen","year":"2018","journal-title":"Br J Psychiatry"},{"issue":"10","key":"10.1016\/j.brs.2025.08.015_bib5","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4088\/JCP.14r09528","article-title":"Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors","volume":"76","author":"Haq","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.brs.2025.08.015_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/acps.13631","article-title":"Outcomes of electroconvulsive therapy in patients with depressive symptoms with versus without comorbid personality disorders\/traits: a systematic review and meta-analysis","volume":"149","author":"Ferrea","year":"2024","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/YCT.0b013e3180330059","article-title":"Anticonvulsants during electroconvulsive therapy: review and recommendations","volume":"23","author":"Sienaert","year":"2007","journal-title":"J ECT"},{"issue":"4 Pt 3","key":"10.1016\/j.brs.2025.08.015_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/15622970902838242","article-title":"Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature","volume":"10","author":"Rubner","year":"2009","journal-title":"World J Biol Psychiatr"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.yebeh.2006.06.013","article-title":"Electroconvulsive therapy in patients with epilepsy","volume":"9","author":"Lunde","year":"2006","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.brs.2025.08.015_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/YCT.0000000000000441","article-title":"Should benzodiazepines and anticonvulsants be used during electroconvulsive therapy? A case study and literature review","volume":"33","author":"Tang","year":"2017","journal-title":"J ECT"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/YCT.0000000000000805","article-title":"Antiepileptics in electroconvulsive therapy: a mechanism-based review of recent literature","volume":"38","author":"Cinderella","year":"2022","journal-title":"J ECT"},{"key":"10.1016\/j.brs.2025.08.015_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.02.2010.2713","article-title":"What works for delirious catatonic mania?","volume":"2010","author":"Vasudev","year":"2010","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.brs.2025.08.015_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/YCT.0000000000000357","article-title":"Concomitant anticonvulsants with bitemporal electroconvulsive therapy: a randomized controlled trial with clinical and neurobiological application","volume":"33","author":"Rakesh","year":"2017","journal-title":"J ECT"},{"issue":"5","key":"10.1016\/j.brs.2025.08.015_bib14","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.brs.2022.08.012","article-title":"Impact of medications, mood state, and electrode placement on ECT outcomes in treatment-refractory psychosis","volume":"15","author":"Ainsworth","year":"2022","journal-title":"Brain Stimul"},{"issue":"1","key":"10.1016\/j.brs.2025.08.015_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/10401239709147770","article-title":"Combined valproate or carbamazepine and electroconvulsive therapy","volume":"9","author":"Zarate","year":"1997","journal-title":"Ann Clin Psychiatr"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/YCT.0b013e31824b64b5","article-title":"Comparing efficacy of ECT with and without concurrent sodium valproate therapy in manic patients","volume":"28","author":"Jahangard","year":"2012","journal-title":"J ECT"},{"issue":"4","key":"10.1016\/j.brs.2025.08.015_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/JCP.0000000000000910","article-title":"Do antiepileptic drugs used during electroconvulsive therapy impact treatment process?","volume":"38","author":"Ak","year":"2018","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/YCT.0000000000000274","article-title":"Seizure adequacy markers and the prediction of electroconvulsive therapy response","volume":"32","author":"Minelli","year":"2016","journal-title":"J ECT"},{"issue":"7","key":"10.1016\/j.brs.2025.08.015_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.22738","article-title":"Seizure duration and electroconvulsive therapy in major depressive disorder","volume":"7","author":"Gillving","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.brs.2025.08.015_bib20","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.4088\/JCP.16m10686","article-title":"Clinical effectiveness and cognitive impact of electroconvulsive therapy for schizophrenia: a large retrospective study","volume":"78","author":"Kaster","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.brs.2025.08.015_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jad.2010.05.008","article-title":"Comparison of electroconvulsive therapy (ECT) with or without anti-epileptic drugs in bipolar disorder","volume":"127","author":"Virupaksha","year":"2010","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.brs.2025.08.015_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000343490","article-title":"Assessment of cognitive impairments and seizure characteristics in electroconvulsive therapy with and without sodium valproate in manic patients","volume":"67","author":"Haghighi","year":"2013","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.brs.2025.08.015_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/NDT.S59375","article-title":"Influence of valproate on the required dose of propofol for anesthesia during electroconvulsive therapy of bipolar affective disorder patients","volume":"10","author":"Hizli","year":"2014","journal-title":"Neuropsychiatric Dis Treat"},{"key":"10.1016\/j.brs.2025.08.015_bib24","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2147\/NDT.S134503","article-title":"Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy","volume":"13","author":"Joo","year":"2017","journal-title":"Neuropsychiatric Dis Treat"},{"key":"10.1016\/j.brs.2025.08.015_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114149","article-title":"Carbamazepine\/oxcarbazepine and valproate have different effects on the electroconvulsive therapy seizure threshold","volume":"304","author":"Pahuja","year":"2021","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.brs.2025.08.015_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/YCT.0000000000000716","article-title":"Factors associated with seizure adequacy along the course of electroconvulsive therapy","volume":"37","author":"Tedeschi","year":"2021","journal-title":"J ECT"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00124509-200606000-00013","article-title":"Combined use of lamotrigine and electroconvulsive therapy in bipolar depression: a case series","volume":"22","author":"Penland","year":"2006","journal-title":"J ECT"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/YCT.0b013e3181e63318","article-title":"Concurrent use of lamotrigine and electroconvulsive therapy","volume":"27","author":"Sienaert","year":"2011","journal-title":"J ECT"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/YCT.0000000000000621","article-title":"Psychotropic medication effects on seizure threshold and seizure duration during electroconvulsive therapy stimulus titration","volume":"36","author":"Chiao","year":"2020","journal-title":"J ECT"},{"key":"10.1016\/j.brs.2025.08.015_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpsychires.2024.08.037","article-title":"Trajectory of associative memory impairment during electroconvulsive therapy in depression","volume":"179","author":"Ji","year":"2024","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.brs.2025.08.015_bib31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jad.2024.12.028","article-title":"Who is at risk of long-term subjective memory impairment after electroconvulsive therapy?","volume":"372","author":"Tornhamre","year":"2025","journal-title":"J Affect Disord"},{"issue":"7","key":"10.1016\/j.brs.2025.08.015_bib32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1176\/ajp.152.7.995","article-title":"Predictors of retrograde amnesia following ECT","volume":"152","author":"Sobin","year":"1995","journal-title":"Am J Psychiatr"},{"issue":"12","key":"10.1016\/j.brs.2025.08.015_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv067","article-title":"Predicting retrograde autobiographical memory changes following electroconvulsive therapy: relationships between individual, treatment, and early clinical factors","volume":"18","author":"Martin","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.brs.2025.08.015_bib35","first-page":"218","article-title":"Clinical global impressions. ECDEU assessment manual for psychopharmacology, revised. Rockville, MD: US dept","author":"Guy","year":"1976","journal-title":"of Health, Education, and Welfare"},{"issue":"1","key":"10.1016\/j.brs.2025.08.015_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/YCT.0000000000000703","article-title":"Need for standardization of measurement of time to reorientation as a predictor of cognitive adverse effects of electroconvulsive therapy","volume":"37","author":"Tripathi","year":"2021","journal-title":"J ECT"},{"issue":"7","key":"10.1016\/j.brs.2025.08.015_bib37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/0004867419839139","article-title":"Royal Australian and New Zealand college of psychiatrists professional practice guidelines for the administration of electroconvulsive therapy","volume":"53","author":"Weiss","year":"2019","journal-title":"Aust N Z J Psychiatr"},{"key":"10.1016\/j.brs.2025.08.015_bib38","series-title":"The practice of electroconvulsive therapy","year":"2025"},{"key":"10.1016\/j.brs.2025.08.015_bib39","series-title":"The ECT handbook","author":"Ferrier","year":"2019"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_491_22","article-title":"Clinical practice guidelines for the use of electroconvulsive therapy","volume":"65","author":"Thirthalli","year":"2023","journal-title":"Indian J Psychiatry"},{"issue":"2","key":"10.1016\/j.brs.2025.08.015_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00124509-200606000-00008","article-title":"Patterns of psychotropic medication use among patients with severe depression referred for electroconvulsive therapy","volume":"22","author":"Rasmussen","year":"2006","journal-title":"J ECT"},{"key":"10.1016\/j.brs.2025.08.015_bib42","unstructured":"Viatris Inc. Lyrica (pregabalin) [package insert]. U S Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/209501s010lbl.pdf Revised 25 April 2025."}],"container-title":["Brain Stimulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X25003080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X25003080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:53:38Z","timestamp":1758603218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1935861X25003080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1935861X25003080"],"URL":"https:\/\/doi.org\/10.1016\/j.brs.2025.08.015","relation":{},"ISSN":["1935-861X"],"issn-type":[{"value":"1935-861X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between concomitant anticonvulsants and clinical and cognitive outcomes of electroconvulsive therapy for depression","name":"articletitle","label":"Article Title"},{"value":"Brain Stimulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brs.2025.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}